Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Fraser

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Vaccine|December 28, 2010
Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrumentKatrina F Brown, Ruth Shanley, Noel A L Cowley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 2019
A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapyKatharine Mackett, Sukhbinder Dhesy-Thind, Elysia K Donovan, et al.
Brain Communications|August 16, 2021
Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer's diseaseDimitrios I Sideris, John S H Danial, Derya Emin, et al.
EMBO Molecular Medicine|September 1, 2017
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variantPeter Thornton, Jean Sevalle, Michael J Deery, et al.
Neurobiology of Disease|August 25, 2019
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivoDarren J Schofield, Lorraine Irving, Laura Calo, et al.
Journal of Medicinal Chemistry|January 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate CancerJames S Scott, Laura Evans, Peter C Astles, et al.
Communications Chemistry|May 19, 2026
The rise and fall of SARM1 base-exchange inhibitorsThomas Lundbäck, Vijay Chandrasekar, Chendi Gu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Vaccine|December 28, 2010
Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrumentKatrina F Brown, Ruth Shanley, Noel A L Cowley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 2019
A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapyKatharine Mackett, Sukhbinder Dhesy-Thind, Elysia K Donovan, et al.
Brain Communications|August 16, 2021
Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer's diseaseDimitrios I Sideris, John S H Danial, Derya Emin, et al.
EMBO Molecular Medicine|September 1, 2017
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variantPeter Thornton, Jean Sevalle, Michael J Deery, et al.
Neurobiology of Disease|August 25, 2019
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivoDarren J Schofield, Lorraine Irving, Laura Calo, et al.
Journal of Medicinal Chemistry|January 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate CancerJames S Scott, Laura Evans, Peter C Astles, et al.
Communications Chemistry|May 19, 2026
The rise and fall of SARM1 base-exchange inhibitorsThomas Lundbäck, Vijay Chandrasekar, Chendi Gu, et al.
Pageof 4